DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fabrazyme (Agalsidase Beta) - News

 
 



News related to Fabrazyme (Agalsidase Beta) and/or conditions it is approved for

Fabry Disease (Symptoms and Life Expectancy)
Source: MedicineNet Deafness Specialty [2017.05.10]
Title: Fabry Disease (Symptoms and Life Expectancy)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 5/10/2017 12:00:00 AM

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017